上海安领科生物医药有限公司 Mediaroom - PR Newswire APAC

Search

上海安领科生物医药有限公司

Latest News

Allink Biotherapeutics Completes $47M Extension Rounds of Series A to Accelerate Clinical Programs and Novel Platforms Development

* The company secured $47 million through extension rounds of Series A led by Legend Capital and ...

2025-12-16 21:30 1541

Allink Biotherapeutics Completes $47M Extension Rounds of Series A to Accelerate Clinical Programs and Novel Platforms Development

* The company secured $47 million through extension rounds of Series A led by Legend Capital and ...

2025-12-16 08:30 1637

Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline

The series A investment round secures resources for advancing global Phase I/II clinical programs a...

2024-11-28 21:06 4184